Evaluation of serum adenosine deaminase activity in acute lymphoid leukemia in Erbil city

  • Salim Khalid Mohammad Department of clinical analysis, College of pharmacy, Hawler medical university, Erbil-Iraq
  • Sardar Nouri Ahmed Department of clinical biochemistry, College of Medicine, Hawler medical university, Erbil-Iraq
Keywords: Serum adenosine deaminase (ADA), acute lymphoid leukemia, immunity

Abstract

Background and objectives: Adenosine deaminase (ADA), is an enzyme that catalyzes hydrolytic deamination of either adenosine or deoxy adenosine to produce inosine and deoxy inosine respectively. The aim of the present study is to evaluate the serum ADA activity in acute lymphoid leukemia.

Method: A prospective study was carried out from January to June 2011 by the clinical biochemistry department in College of Medicine-Hawler Medical University on (30) patients with Acute lymphoid leukemia (group 1), and (30) healthy individuals, (group 2).

Results: The mean value of serum ADA activity was significantly lower in Acute lymphoid leukemia (group 1), than those of healthy individuals, (group 2) (p<0.01), and both ions   Na+ and K+ acted as an activators for Serum ADA activity.

Conclusion: Based on the findings, it can be concluded that in acute lymphoid leukemia the activity of Serum ADA was decreased due to decline in the immunity.

References

- Adams. A, and Harkens R.A. Adenosine deaminase activity in Thymus and other human tissues. Clin. Exp. Immunol. 1976. 26:647-9.

- Kohler,L. and Berz,J. Clinical chemistry. 1962. 8: 133.

- Daddona,P.E.; Schewach, D.S.; and Kelly, W.N. Human adenosine deaminase, cDNA and complete primary amino acid sequence.J. Biol. Chem. 1984. 529, 12: 101-106.

- Chang,Z.; Nygaard,P.; Chinualt, A.C. and Kellems, R.E. Deduced amino acid sequence of Escherichia Coli adenosine deaminase reveals evolutionarily conserved amino acid residues: implications for analytic function. Biochemistry. 1991. 30:2273-2280.

- Wilson, D.K.; Rudolph,F.B. and Quiocho,F.A. Atomic structure of adenosine deaminase With transition-state analogs: understanding catalysis immunodeficiency mutations science; 1980. 252:1278-1284.

- Dixon, M. and Webb,E.C. Enzymes. Longon. 3rd edition. New York. 1984

- Meibaum,K.W. and Dobrys, Z. W. Immunochemical properties of the serum patients after regeneration from the protein-tannin compounds. Nature, 1962. 193:1286-1288.

- Kohler,L. and Berz,J. Clinical chemistry. 1962. 8: 133.

- Voet,D.; Voet,J.G.; and Pratt,C.W. Fundamentals of Biochemistry life at the molecular level. 2nd ed. John Wiley & Sons, Inc. USA. 2006

- Schgal VN,; Bhattachary SN,; and Shahi. Lymphocyte ADA activity in leprosy during and after treatment of reaction. Clin. Exp. Dermatol. 1992. 17:20-23.

- Hasan G. H, and, Rwandzy.G.H .Elevation of adenosine deaminase enzyme and the role of metal ions in jaundice sera. Zanko. Journal of pure and applied science. Salahaddin University. 2002. vol.14, (2).

- Sari RA.; Taysi S.;Yilmaz O. and Bakam N. Correlation of serum levels of adenosine deaminase activity and its isoenzymes disease activity in RA.Clin Exp. Rheumatol;. 2003. 21(1).

- Kumar R.; Pachor S.B.; and Senger.G.K,. Study of adenosine deaminase activity in Various arthritic conditions. 1994. Vol.1, (2): 92-4.

- Dorma MM. and Dorma O. Diagnostic efficacy of ADA for future therapeutic approaches in immunodeficiency disorders.Lab. Med. Intern. 1996. 13:16-19.

- C Keith Stone. and Rober L. Humphries Current emergency, diagnosis and treatment. 5th edition. Medical publication division. 2004

- Hoffbrand, A.V. Moss P.A.H. and Pettit J.E. Essential hematology.5th edition. Blackwell publishing. USA. 2006

- Giusti, J. and Galanti, B. Estimation of serum adenosine deaminase. 1968. Mal. Inf. Paris. 20:980.

- Daniel,W.W. Biostatistics: A foundation for analysis in the health science. 3rd edition. 1983. John Wiley and Sons. USA.

- John Z. A. Samy K and James J. L. Decreased lymphocyte adenosine deaminase activity in Acute lymphocytic children and their parents. American association for cytotoxicity to T lymphoblasts in vivo. The amirican society of hematology.1981. 21(4);1137-1139.

- BS Michell, CA Ktter, and R,Hey.Alterations of lymphocyte adenosine deaminase activity in leukemic patients. Hematology. 2009: 24:3.

- Robertson. P, Erwin W. G, Fred S R, Amoid Sanderson, and Rochelle Hirschhorn. Severe combined immunodeficiency and adenosine deaminase deficiency. Engl J Med. 1975. 292:714-719.

- WC Yasmineh, RK Brynes, CT Lum and M Abbasnezhad. Adenosine deaminase activity in lymphocytes of normal persons, leukemic patients, and kidney-transplant recipients. Clinical chemistry. 1977. 23:2024-2029.

- Hovi .T, J. F. Smyth, A. C. Allison and S.C. WilliamsRole of adenosine in lymphocyte proliferation. Clinical experiment immunology. 1976. 23, 395-403.

- AL-Taii-Asra. Biochemical studies of 5’-nucleotidase isoenzymes practically purified from sera of animic patients, MS.c. thesis. Tickrit University. 2006

- Sharoiant SG, Antonian AA and Mardanian SS. “Isolation, purification, and comparative study of the properties of ADA from five regions of cattle brain” J. Biochemia. 1994. 59(2):239-245.

- Dugas H. “Bioorganic chemistry” 3rd edition. Springer. 1999: P. 388.

- Colombo MC, Guidoni L, Laio K, Magistrato A, Maurer P, Piana S, et al. Stimulation of catalytic and enzymatic reactions”Chimia 2002. 56:13-19.

Published
2018-10-16
How to Cite
Mohammad, S., & Ahmed, S. (2018). Evaluation of serum adenosine deaminase activity in acute lymphoid leukemia in Erbil city. Zanco Journal of Medical Sciences (Zanco J Med Sci), 16(2), 151-156. https://doi.org/10.15218/zjms.2012.0026
Section
Original Articles